NYSEMKT: AIMAim Immunotech Inc Earnings Dates, Reports, Calls
Aim Immunotech earnings were -$15.8M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest AIM earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$3.3M, up 17.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AIM reported annual earnings of -$17.3M, with -40.2% growth.
AIM earnings history
Current Revenue
$112.0k
Current Earnings
-$15.8M
Current Profit Margin
-14,062.5%
AIM Return on Equity
Current Company
N/A
Current Industry
-21.2%
Current Market
35.8%
AIM undefined
Current Company
-257.4%
Current Industry
-8.7%
AIM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when AIM announces earnings.
AIM undefined
Current Company
-1,047.35%
Current Industry
-3.4%
AIM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
AIM vs Biotech Stocks
Aim Immunotech Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.